U.S. Communications Stock News

Why Ollie's Bargain Outlet Holdings (OLLI) Is Back on Investors' Radar Ollie's Bargain Outlet Holdings (OLLI) has drawn fresh attention after recent share price moves, with the stock down around 8% over the past month and about 25% over the past 3 months. At a recent close of US$81.84 and a market value near US$5.0b, investors are weighing that pullback against the company’s annual revenue of US$2.65b and net income of roughly US$241m. See our latest analysis for Ollie's Bargain Outlet...

LPL Financial Holdings has already reported its April 2026 monthly activity, highlighting total client assets of US$2.48 trillion and a higher share of advisory assets, alongside announcements that several large advisory teams with billions in combined assets joined its platforms. Beneath the routine director equity grants, the combination of strong organic client asset growth and continued advisor recruitment underscores how central LPL’s platform has become for independent wealth managers...

Under Armour (UAA) stock is in focus after recent quarterly results showed flat revenue, an adjusted EBITDA miss, and management commentary pointing to ongoing brand and product transformation in a tough retail backdrop. See our latest analysis for Under Armour. The stock’s 1-day share price return of 3.38% and 7-day gain of 7.42% contrast with a 30-day decline of 12.97% and 90-day drop of 32.43%, while the 1-year total shareholder return is down 17.79%. This suggests recent momentum has...

Earlier in May 2026, CLEAR announced partnerships with Expedia and General Dynamics Information Technology to extend its CLEAR+ and CLEAR1 identity platforms across major travel channels and U.S. federal health and civilian agencies. By embedding CLEAR directly into Expedia’s booking flow and into GDIT’s federal cloud tools, the company is positioning its identity technology as core infrastructure for both commercial travel and government services. Next, we’ll examine how integrating CLEAR1...

In May 2026, Prosperity Bancshares faced renewed scrutiny as analysts pointed to years of muted net interest income growth, flat earnings per share, and expectations for a decline in tangible book value per share, raising concerns about profitability and potential credit quality pressures. These fundamental headwinds, alongside a recent US$75,662 stock sale by director Ned S. Holmes, have sharpened investor focus on whether the bank’s balance sheet strength can absorb higher credit costs...

On 21 May 2026, ACI Worldwide announced it had extended its nearly 20-year partnership with UBX Tanzania Limited to upgrade the core payments infrastructure that supports 18 banks, over 250 ATMs and more than 1.3 million monthly transactions across Tanzania. The renewed agreement allows UBX to serve merchants directly, expand into digital wallets and other value-added services, and almost double its payment-processing capacity over the next five years on a high-availability, PCI-compliant...

Aveanna Healthcare Holdings Inc. recently reported past first-quarter 2026 results, with sales rising to US$647.92 million and net income to US$41.65 million, while basic and diluted EPS from continuing operations reached US$0.19. The company also recorded lower impairment charges than a year ago and slightly raised its full-year 2026 revenue outlook to a range of US$2.56 billion to US$2.58 billion, signaling management confidence despite prior dilution and unusual items affecting recent...

In the first quarter of 2026, Steel Dynamics reported record steel shipments, higher net and operating income, and revenue ahead of expectations, while management highlighted progress commissioning additional aluminum facilities and reaffirmed confidence in strong domestic demand for low‑carbon, locally produced materials. An interesting takeaway is how Steel Dynamics is positioning its expanding aluminum operations and integrated recycling capabilities to serve customers seeking...

In May 2026, Thermo Fisher Scientific Inc. held its 2026 Investor Day and affirmed a quarterly dividend of US$0.47 per share payable on July 15, 2026, while also updating investors on AI integration, capital deployment, and portfolio initiatives following recent leadership changes and the announced US$9.00 billion Clario acquisition. Beyond the dividend, the company’s focus on AI-enabled clinical and laboratory solutions, expanded bioanalytical capacity, and end-to-end drug development...

Amgen has confirmed that executive vice president and chief financial officer Peter Griffith will retire, with former Amgen finance leader Thomas Dittrich rejoining as executive vice president on July 1, 2026, and assuming the CFO role on September 1, 2026, while Griffith stays through January 2027 to support the transition. At the same time, shareholders recently voted against a proposal to require an independent board chair, underscoring investor attention on how Amgen balances board...

In May 2026, Fortive Corporation completed a US$1.10 billion senior unsecured fixed-rate notes offering, issuing 4.750% notes due 2031 and 5.250% notes due 2036, primarily to refinance its 3.150% senior notes maturing in June 2026 and for general corporate purposes. The new callable, unsubordinated notes extend Fortive’s debt maturity profile and modestly increase interest costs, while preserving financial flexibility for ongoing operations and potential future investments. We’ll now...

Why Schneider National (SNDR) is on investors’ radar Schneider National (SNDR) has drawn fresh attention after recent share price moves, with the stock last closing at $33.40. Investors are weighing this against its reported revenue of $5,671.0 million and net income of $97.9 million. See our latest analysis for Schneider National. Recent price action has been strong, with a 30-day share price return of 11.93% and a year to date share price return of 23.84%. The 1 year total shareholder...

In May 2026, Warby Parker announced its first AI-powered “Intelligent Eyewear” frame, developed with Google and Samsung, featuring Gemini integration and Android XR support for everyday, hands-free assistance. This move signals Warby Parker’s push beyond traditional eyewear into AI wearables while insider share sales add an extra layer of uncertainty around the shift. Now we’ll examine how Warby Parker’s Google- and Samsung-backed Intelligent Eyewear initiative could reshape its investment...

First quarter loss widens for Damora Therapeutics (DMRA) Damora Therapeutics (DMRA) reported first quarter results that drew attention, with a net loss of US$27.78 million for the period ended March 31, 2026, compared with US$2.53 million a year earlier. See our latest analysis for Damora Therapeutics. The share price has been volatile, with a 1 day share price return of 1.77% and year to date share price return of 15.95%. The 1 year total shareholder return is very large, but longer term...

MakeMyTrip (MMYT) is back in focus after its latest quarterly and full year 2026 results, where lower profit and an earnings miss contrasted with higher gross bookings, rising finance costs, and ongoing geopolitical pressures on travel demand. See our latest analysis for MakeMyTrip. The stock’s recent slide, including a 30 day share price return of down 6.82% and a year to date share price return of down 47.8%, contrasts sharply with a 3 year total shareholder return of 62.12%. This suggests...

Spire Global (SPIR) is back on investor radar after two business updates: an expanded Cirrus weather intelligence offering for energy traders and a new aircraft tracking data agreement with Amadeus IT Group. See our latest analysis for Spire Global. The share price has moved to US$21.16 after a 10.15% 1 day share price return and a 129.75% 90 day share price return, alongside a 1 year total shareholder return of 98.87%, reflecting strong momentum despite the recent earnings shortfall and...

In May 2026, Immunovant, Inc. reported a wider quarterly and full-year net loss, with fourth-quarter net loss rising to US$147.86 million and full-year net loss to US$505.61 million, while maintaining a cash balance above US$900 million and recording no revenue. At the same time, Immunovant released encouraging Week 16 data for its lead FcRn inhibitor IMVT-1402 in difficult-to-treat rheumatoid arthritis and discontinued batoclimab after Phase 3 failures, signaling a concentrated push behind...

Earlier in May 2026, Teva Pharmaceutical Industries presented new real-world data from its three-year IMPACT-TD Registry at the American Psychiatric Association meeting, revealing that young adults with mood disorders and tardive dyskinesia often face delayed recognition and low formal diagnosis rates despite substantial daily life impact. The findings underline a pronounced diagnostic gap in tardive dyskinesia for patients under 40, especially those aged 18–29, who report high psychological...

Earlier this week, ESAB introduced the Sentinel A70 PRO, its first premium flip-up automatic welding helmet for heavy industry, featuring dual flip-up functionality, advanced optics, integrated lighting, Bluetooth connectivity, and second-generation True-Color auto-darkening technology designed to enhance comfort and productivity. The launch underscores ESAB’s push to differentiate through higher-tech equipment at a time when analysts remain concerned about its limited organic revenue growth...

Popular (BPOP) has drawn fresh attention after two years of expanding net interest margin, strong quarterly results and annualized EPS growth of 30.9%, with recent options activity pointing to expectations of sharper share price moves. See our latest analysis for Popular. Recent governance changes at the annual meeting and a renewed performance focus from management sit alongside a 19.5% year to date share price return and a 50.5% 1 year total shareholder return, indicating momentum that...

Rising mortgage rates recently hit a one month high, stirring fresh worries about housing affordability and future demand. Griffon (GFF), a home construction materials company, dropped 3.9% in that session as investors reassessed sector risks. See our latest analysis for Griffon. Despite the recent drop on mortgage rate concerns, Griffon’s recent 7 day share price return of 3.7% and year to date share price return of 13.11% contrast with its 30 day share price decline of 6.83%, while the 1...

Brookfield Wealth Solutions Ltd. reported first-quarter 2026 results, with revenue of US$1.66 billion down from US$2.62 billion a year earlier and a wider net loss of US$609 million versus US$326 million, signaling a tougher operating period. The combination of sharply lower revenue and a much larger loss suggests the business is facing meaningful pressure on both growth and profitability drivers. Next, we’ll examine how this steep revenue drop and expanding loss profile shape Brookfield...

Record quarter puts HCI Group (HCI) in focus HCI Group (HCI) has drawn fresh attention after reporting the best first quarter in its history, pairing record profitability and cash flows with the start of a US$80 million share repurchase program. See our latest analysis for HCI Group. Despite the record quarter and active US$80 million buyback, recent share price returns have been mixed. The stock is down year to date but supported by a strong three year total shareholder return above 200%,...

Nuvalent recently presented pivotal ALKOVE-1 data for neladalkib in TKI pre-treated advanced ALK-positive NSCLC and preliminary ARROS-1 data for zidesamtinib in ROS1-positive solid tumors other than NSCLC at the 2026 ASCO Annual Meeting, supporting its recent FDA NDA submission and ongoing Phase 3 ALKAZAR trial. An interesting angle is how zidesamtinib’s early results in ROS1-positive tumors beyond lung cancer highlight Nuvalent’s effort to broaden targeted therapy applications. We’ll now...